Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study: Corrigendum

Sarbjit S Saini, Carsten Bindslev-Jensen, Marcus Maurer, Jean-Jacques Grob, Emel Bülbül Baskan, Mary S Bradley, Janice Canvin, Abdelkader Rahmaoui, Panayiotis Georgiou, Oral Alpan, Sheldon Spector, Karin Rosén

Research output: Contribution to journalComment/debateResearchpeer-review

Original languageEnglish
JournalJournal of Investigative Dermatology
Volume135
Issue number3
Pages (from-to)925
ISSN0022-202X
DOIs
Publication statusPublished - Mar 2015

Cite this